Complii faces funding pressure with 0.14 quarters of cash remaining
Complii FinTech Solutions ended September with $168,000 in cash after a $1.20 million operating cash outflow, leaving just 0.14 quarters of funding at the reported burn rate. Management points to cost reductions, stronger revenue and a $1.24 million R&D rebate received in October as the route to improved liquidity.
- $168,000 cash at 30 September, down from $1.009 million
- $1.20 million operating cash outflow during Q1 FY27
- $1.24 million R&D rebate received after quarter end
- $14.365 billion raised across 801 platform offerings
- Four new PrimaryMarkets Trading Hub mandates signed after quarter end
Add us as a preferred source on Google
Cash runway falls to 0.14 quarters
Complii FinTech Solutions (ASX:CF1) finished the September quarter with only $168,000 in cash after its operations consumed $1.203 million, a liquidity position the Appendix 4C translates into an estimated 0.14 quarters of funding at the current burn rate.
Cash fell from $1.009 million at the start of the quarter despite $364,000 of net financing inflows, including $449,000 received under an R&D loan. The company reported $1.295 million in customer receipts, against $1.647 million of staff costs and $738,000 of administration and corporate costs. Directors and related parties received $177,000 during the quarter.
Management said it does not expect operating cash flow to remain at the current level, citing headcount reductions, cost-saving initiatives and anticipated revenue improvement. The company also disclosed that it received a $1.239 million R&D rebate in October, after the reporting date, meaning that payment is not reflected in the September quarter-end cash balance.
Cost reductions face a demanding test
Total revenue and other income was $1.35 million for Q1 FY27, while total expenses were $2.4 million. Complii said quarterly operating expenses excluding one-off payments fell by $500,000 year on year, although the quarter included $236,000 of payments linked to cost-saving initiatives.
The balance sheet also carries a $2 million convertible-note facility drawn at quarter end, with the notes carrying 12% annual interest and maturing in March 2028. That funding formed part of the $2 million convertible note raise previously reported as supporting platform upgrades and expansion. The R&D loan, which had a 30 November 2026 maturity, was retired after quarter end when the FY26 tax return was received.
Platform activity remains substantial
Operationally, Complii’s capital-raising platform processed approximately $14.365 billion across 801 offerings during the quarter. The company continued work to onboard its first institutional customer, although expanded requirements have pushed the expected go-live into Q2 FY27. Its architecture modernisation program advanced from about 30% to 70% completion, while the lighter Complii Lite compliance product moved into customer marketing and onboarding.
PrimaryMarkets reported lower transactional revenue for the quarter but said it signed four significant Trading Hub mandates after quarter end, including Loftus Peak, Good Drinks Australia, Melvista Lithium and an unnamed privately held advanced manufacturing company. Mintegrity reported completed projects and a strong prospective pipeline, while ThinkCaddie added customer deployments and progressed a technology migration intended to deliver cost savings.
Funding improvement now depends on execution
Complii said group annual recurring revenue increased 2.3% year on year and that it remains focused on client acquisition, cross-selling and operating efficiency. It has not proposed another immediate capital raising, but said it may seek an advance against FY27 accrued R&D expenditure in the December quarter using the facility that funded the earlier R&D loan.
The crucial evidence will come from the next quarter’s cash balance rather than the size of the platform’s transaction volumes. Complii must convert the institutional implementation, new Trading Hub mandates and compliance pipeline into cash receipts quickly enough for the October rebate and reduced costs to alter the funding calculation.
Bottom Line?
The October R&D rebate provides near-term breathing room, but Q2 cash generation will determine whether cost cuts are changing Complii’s funding trajectory or merely extending it.
Questions in the middle?
- How much of the October R&D rebate remains available after the company’s September cash shortfall?
- Will the institutional implementation and four new Trading Hub mandates produce material recurring revenue in Q2 FY27?
- Can operating cash outflows fall fast enough to avoid another funding requirement before the next R&D advance?
Sources
1-
September 2026 Quarterly Activities Report and Appendix 4C (opens in a new tab)Verified source. Complii Fintech Solutions Ltd · 30 Oct 2026